US Stock MarketDetailed Quotes

Alzamend Neuro (ALZN)

Watchlist
  • 1.110
  • -0.020-1.77%
Close Apr 24 16:00 ET
  • 1.150
  • +0.040+3.60%
Post 19:35 ET
4.22MMarket Cap-0.30P/E (TTM)

Alzamend Neuro (ALZN) Income Statement

Quarterly+Annual
YOY yoy
Hide blank lines yoy
(Q3)Jan 31, 2026
(Q2)Oct 31, 2025
(Q1)Jul 31, 2025
(FY)Apr 30, 2025
(Q4)Apr 30, 2025
(Q3)Jan 31, 2025
(Q2)Oct 31, 2024
(Q1)Jul 31, 2024
(FY)Apr 30, 2024
(Q4)Apr 30, 2024
Total revenue
0
0
0
0
0
0
0
0
0
0
Operating revenue
--0
--0
--0
--0
--0
--0
--0
--0
--0
--0
Cost of revenue
Gross profit
Operating expense
111.84%2.2M
-26.51%998.11K
180.57%2.7M
-54.75%4.5M
33.98%1.14M
-61.00%1.04M
-53.20%1.36M
-72.70%962.41K
-33.17%9.94M
-74.28%850.06K
Selling and administrative expenses
55.69%919.03K
-21.51%821.83K
26.92%959.33K
-11.50%3.08M
3.32%688.78K
-21.42%590.3K
15.70%1.05M
-34.83%755.83K
-53.09%3.48M
-59.77%666.63K
-Selling and marketing expense
--50K
--0
275.00%150K
40.42%347.3K
--3.3K
--0
--304K
-83.83%40K
-66.69%247.33K
--0
-General and administrative expense
47.22%869.03K
10.61%821.83K
13.06%809.33K
-15.47%2.73M
2.83%685.48K
-21.42%590.3K
-17.90%742.98K
-21.55%715.83K
-51.58%3.24M
-52.71%666.63K
Research and development costs
185.98%1.28M
-43.33%176.28K
742.75%1.74M
-78.08%1.41M
145.41%450.16K
-76.58%447.11K
-84.42%311.09K
-91.27%206.57K
-13.31%6.46M
-88.87%183.43K
Operating profit
-111.84%-2.2M
26.51%-998.11K
-180.57%-2.7M
54.75%-4.5M
-33.98%-1.14M
61.00%-1.04M
53.20%-1.36M
72.70%-962.41K
33.17%-9.94M
74.28%-850.06K
Net non-operating interest income expense
33.78%-1.34K
24.21%-2.65K
79.32%-2.48K
-78.49%-18.03K
65.26%-509
18.85%-2.02K
18.93%-3.5K
-554.28%-12.01K
-31.16%-10.1K
-182.27%-1.47K
Non-operating interest expense
-33.78%1.34K
-24.21%2.65K
-79.32%2.48K
78.49%18.03K
-65.26%509
-18.85%2.02K
-18.93%3.5K
554.28%12.01K
31.16%10.1K
182.27%1.47K
Other net income (expense)
Income before tax
-111.56%-2.2M
26.50%-1M
-177.37%-2.7M
54.61%-4.51M
-33.81%-1.14M
60.96%-1.04M
53.15%-1.36M
72.38%-974.41K
33.14%-9.95M
74.24%-851.53K
Income tax
Net income
-111.56%-2.2M
26.50%-1M
-177.37%-2.7M
54.61%-4.51M
-33.81%-1.14M
60.96%-1.04M
53.15%-1.36M
72.38%-974.41K
33.14%-9.95M
74.24%-851.53K
Net income continuous Operations
-111.56%-2.2M
26.50%-1M
-177.37%-2.7M
54.61%-4.51M
-33.81%-1.14M
60.96%-1.04M
53.15%-1.36M
72.38%-974.41K
33.14%-9.95M
74.24%-851.53K
Minority interest income
Net income attributable to the parent company
-111.56%-2.2M
26.50%-1M
-177.37%-2.7M
54.61%-4.51M
-33.81%-1.14M
60.96%-1.04M
53.15%-1.36M
72.38%-974.41K
33.14%-9.95M
74.24%-851.53K
Preferred stock dividends
590.23K
502.85K
33.73K
53.65K
Other preferred stock dividends
Net income attributable to common stockholders
-104.91%-2.2M
29.29%-1M
-177.37%-2.7M
48.68%-5.11M
-92.86%-1.64M
59.69%-1.07M
51.30%-1.42M
72.38%-974.41K
33.14%-9.95M
74.24%-851.53K
Basic earnings per share
66.86%-0.58
91.69%-0.3
88.79%-1.28
91.45%-11.32
80.20%-2.1089
94.84%-1.75
90.95%-3.61
76.41%-11.42
42.19%-132.33
84.50%-10.65
Diluted earnings per share
66.86%-0.58
91.69%-0.3
88.79%-1.28
91.45%-11.32
80.20%-2.1089
94.84%-1.75
90.95%-3.61
76.41%-11.42
42.19%-132.33
84.50%-10.65
Dividend per share
Currency Unit
USD
USD
USD
USD
USD
USD
USD
USD
USD
USD
Accounting Standards
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
Audit Opinions
--
--
--
Unqualified Opinion with Explanatory Notes
--
--
--
--
Unqualified Opinion with Explanatory Notes
--
(Q3)Jan 31, 2026(Q2)Oct 31, 2025(Q1)Jul 31, 2025(FY)Apr 30, 2025(Q4)Apr 30, 2025(Q3)Jan 31, 2025(Q2)Oct 31, 2024(Q1)Jul 31, 2024(FY)Apr 30, 2024(Q4)Apr 30, 2024
Total revenue 0000000000
Operating revenue --0--0--0--0--0--0--0--0--0--0
Cost of revenue
Gross profit
Operating expense 111.84%2.2M-26.51%998.11K180.57%2.7M-54.75%4.5M33.98%1.14M-61.00%1.04M-53.20%1.36M-72.70%962.41K-33.17%9.94M-74.28%850.06K
Selling and administrative expenses 55.69%919.03K-21.51%821.83K26.92%959.33K-11.50%3.08M3.32%688.78K-21.42%590.3K15.70%1.05M-34.83%755.83K-53.09%3.48M-59.77%666.63K
-Selling and marketing expense --50K--0275.00%150K40.42%347.3K--3.3K--0--304K-83.83%40K-66.69%247.33K--0
-General and administrative expense 47.22%869.03K10.61%821.83K13.06%809.33K-15.47%2.73M2.83%685.48K-21.42%590.3K-17.90%742.98K-21.55%715.83K-51.58%3.24M-52.71%666.63K
Research and development costs 185.98%1.28M-43.33%176.28K742.75%1.74M-78.08%1.41M145.41%450.16K-76.58%447.11K-84.42%311.09K-91.27%206.57K-13.31%6.46M-88.87%183.43K
Operating profit -111.84%-2.2M26.51%-998.11K-180.57%-2.7M54.75%-4.5M-33.98%-1.14M61.00%-1.04M53.20%-1.36M72.70%-962.41K33.17%-9.94M74.28%-850.06K
Net non-operating interest income expense 33.78%-1.34K24.21%-2.65K79.32%-2.48K-78.49%-18.03K65.26%-50918.85%-2.02K18.93%-3.5K-554.28%-12.01K-31.16%-10.1K-182.27%-1.47K
Non-operating interest expense -33.78%1.34K-24.21%2.65K-79.32%2.48K78.49%18.03K-65.26%509-18.85%2.02K-18.93%3.5K554.28%12.01K31.16%10.1K182.27%1.47K
Other net income (expense)
Income before tax -111.56%-2.2M26.50%-1M-177.37%-2.7M54.61%-4.51M-33.81%-1.14M60.96%-1.04M53.15%-1.36M72.38%-974.41K33.14%-9.95M74.24%-851.53K
Income tax
Net income -111.56%-2.2M26.50%-1M-177.37%-2.7M54.61%-4.51M-33.81%-1.14M60.96%-1.04M53.15%-1.36M72.38%-974.41K33.14%-9.95M74.24%-851.53K
Net income continuous Operations -111.56%-2.2M26.50%-1M-177.37%-2.7M54.61%-4.51M-33.81%-1.14M60.96%-1.04M53.15%-1.36M72.38%-974.41K33.14%-9.95M74.24%-851.53K
Minority interest income
Net income attributable to the parent company -111.56%-2.2M26.50%-1M-177.37%-2.7M54.61%-4.51M-33.81%-1.14M60.96%-1.04M53.15%-1.36M72.38%-974.41K33.14%-9.95M74.24%-851.53K
Preferred stock dividends 590.23K502.85K33.73K53.65K
Other preferred stock dividends
Net income attributable to common stockholders -104.91%-2.2M29.29%-1M-177.37%-2.7M48.68%-5.11M-92.86%-1.64M59.69%-1.07M51.30%-1.42M72.38%-974.41K33.14%-9.95M74.24%-851.53K
Basic earnings per share 66.86%-0.5891.69%-0.388.79%-1.2891.45%-11.3280.20%-2.108994.84%-1.7590.95%-3.6176.41%-11.4242.19%-132.3384.50%-10.65
Diluted earnings per share 66.86%-0.5891.69%-0.388.79%-1.2891.45%-11.3280.20%-2.108994.84%-1.7590.95%-3.6176.41%-11.4242.19%-132.3384.50%-10.65
Dividend per share
Currency Unit USDUSDUSDUSDUSDUSDUSDUSDUSDUSD
Accounting Standards US-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAP
Audit Opinions ------Unqualified Opinion with Explanatory Notes--------Unqualified Opinion with Explanatory Notes--
Market Insights
China Concept Stocks
View More
Middle East conflict spreads to the stock market! How should investors respond?
Signs of restarting the second round of US-Iran talks have emerged. According to reports, Iran's foreign minister arrived in Pakistan on Fri Show More